Transforming Growth Factor Beta 3 Is Required for Excisional Wound Repair In Vivo

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Le, Mark ^a   Naridze, Rachelle ^a   Morrison, Jasmine ^a   Biggs, Leah C ^a   Rhea, Lindsey ^a   Schutte, Brian C ^b   Kaartinen, Vesa ^c   Dunnwald, Martine ^a  

^a UNIVERSITY OF IOWA   (United States)

^b Michigan State University ^*  (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA3; TRANSFORMING GROWTH FACTOR BETA3;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EPIDERMIS; EPITHELIZATION; EXCISION; FEMALE; GRANULATION TISSUE; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN INJURY; WILD TYPE; WOUND CLOSURE; WOUND HEALING;

ANIMALS; ANTIBODIES, NEUTRALIZING; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CICATRIX; EPITHELIUM; FEMALE; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA3; WOUND HEALING;

EID: 84868140143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048040     Document Type: Article

References (49)

1. Martin P, (1997) Wound healing-Aiming for perfect skin regeneration. Science 276: 75-81.
2. Singer AJ, Clark RAF, (1999) Cutaneous wound healing. N Engl J Med 341: 738-746.
3. Baum CL, Arpey CJ, (2005) Normal cutaneous wound healing: clinical correlations with cellular and molecular events. Dermatol Surg 31: 674-686.
4. Werner S, Grose R, (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83: 835-870.
5. Massagué J, (1990) The transforming growth factor-beta family. Annu Rev Cell Biol 6: 597-641.
6. Wharton K, Derynck R, (2009) TGFbeta family signaling: novel insights in development and disease. Development 136: 3691-3697.
7. Millan FA, Denhez F, Kondaiah P, Akhurst RJ, (1991) Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 111: 131-143.
8. Pelton RW, Dickinson ME, Moses HL, Hogan BL, (1990) In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2. Development 110: 609-620.
9. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI, (1991) Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 115: 1091-1105.
10. Wu MY, Hill CS, (2009) Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell 16: 329-343.
11. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
12. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, et al. (1997) TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124: 2659-2670.
13. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, et al. (1995) Abnormal lung development and cleft palate in mice lacking TGF-b3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11: 415-421.
14. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, et al. (1995) Transforming growth factor beta 3 is required for secondary palate fusion. Nat Genet 11: 409-414.
15. Levine JH, Moses HL, Gold LI, Nanney LB, (1993) Spatial and temporal patterns of immunoreactive transforming growth factor beta1, beta2 and beta3 during excisional wound repair. Am J Pathol 143: 368-380.
16. O'Kane S, Ferguson MW, (1997) Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 29: 63-78.
17. Shah M, Foreman DM, Ferguson MWJ, (1995) Neutralisation of TGF-beta1 and TGF-beta2 or exogenous addition of TGF beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108: 985-1002.
18. Crowe MJ, Doetschman T, Greenhalgh DG, (2000) Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol 115: 3-11.
19. Amendt C, Mann A, Schirmacher P, Blessing M, (2002) Resistance of keratinocytes to TGFbeta-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds. J Cell Sci 115: 2189-2198.
20. Martinez-Ferrer M, Afshar-Sherif AR, Uwamariya C, de Crombrugghe B, Davidson JM, et al. (2010) Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. Am J Pathol 176: 98-107.
21. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, et al. (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1: 260-266.
22. Li J, Foitzik K, Calautti E, Baden H, Doetschman T, et al. (1999) TGF-beta3, but not TGF-beta1, protects keratinocytes against 12-O-tetradecanoylphorbol-13-acetate-induced cell death in vitro and in vivo. J Biol Chem 274: 4213-4219.
23. Bandyopadhyay B, Fan J, Guan S, Li Y, Chen M, et al. (2006) A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol 172: 1093-1105.
24. Occleston NL, Laverty HG, O'Kane S, Ferguson MW, (2008) Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed 19: 1047-1063.
25. Ferguson MW, Duncan J, Bond J, Bush J, Durani P, et al. (2009) Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet 373: 1264-1274.
26. Waddington SN, Crossley R, Sheard V, Howe SJ, Buckley SM, et al. (2010) Gene delivery of a mutant TGFbeta3 reduces markers of scar tissue formation after cutaneous wounding. Mol Ther 18: 2104-2111.
27. Yang LT, Li WY, Kaartinen V, (2008) Tissue-specific expression of Cre recombinase from the Tgfb3 locus. Genesis 46: 112-118.
28. Biggs LC, Rhea L, Schutte BC, Dunnwald M (2011) Interferon Regulatory Factor 6 Is Necessary, but Not Sufficient, for Keratinocyte Differentiation. J Invest Dermatol.
29. Bailey CM, Kahalkahali-Ellis Z, Kondo S, Margaryan NV, Seftor REB, et al. (2005) Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6. Identification of a novel serpin partnership. J Biol Chem 280: 34210-34217.
30. Hager B, Bickenbach JR, Fleckman P, (1999) Long term culture of murine epidermal keratinocytes. J Invest Dermatol 112: 971-976.
31. Lin HY, Kao CH, Lin KM, Kaartinen V, Yang LT, (2011) Notch signaling regulates late-stage epidermal differentiation and maintains postnatal hair cycle homeostasis. PLoS One 6: e15842.
32. Soriano P, (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21: 70-71.
33. Yang LT, Kaartinen V, (2007) Tgfb1 expressed in the Tgfb3 locus partially rescues the cleft palate phenotype of Tgfb3 null mutants. Dev Biol 312: 384-395.
34. Xu X, Han J, Ito Y, Bringas P, Urata MM, et al. (2006) Cell autonomous requirement for Tgfbr2 in the disappearance of medial edge epithelium during palatal fusion. Dev Biol 297: 238-248.
35. Knight AS, Schutte BC, Jian R, Dixon MJ, (2006) Developmental expression analysis of the mouse and chick orthologues of IRF6: the gene mutated in Van der Woude syndrome. Dev Dyn 235: 1441-1447.
36. Ingraham CR, Kinoshita A, Kondo S, Yang B, Sajan S, et al. (2006) Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet 38: 1335-1340.
37. Reynolds AJ, Chaponnier C, Jahoda CAB, Gabbiani G, (1993) A quantitative study of the differential expression of alpha-smooth muscle actin in cell populations of follicular and non-follicular origin. J Invest Dermatol 101: 577-583.
38. Hinz B, (2007) Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127: 526-537.
39. Vicente-Manzanares M, Webb DJ, Horwitz AR, (2005) Cell migration at a glance. J Cell Sci 118: 4917-4919.
40. Nishimura SL, (2009) Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. Am J Pathol 175: 1362-1370.
41. Fowlis DJ, Cui W, Johnson SA, Balmain A, Akhurst RJ, (1996) Altered epidermal cell growth control in vivo by inducible expression of transforming growht factor B1 in the skin of transgenic mice. Cell Growth & Diff 7: 679-687.
42. Stojadinovic O, Pastar I, Vukelic S, Mahoney MG, Brennan D, et al. (2008) Deregulation of keratinocyte differentiation and activation: a hallmark of venous ulcers. J Cell Mol Med 12: 2675-2690.
43. Xu X, Han J, Ito Y, Bringas P Jr, Deng C, et al. (2008) Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-beta/BMP signaling during tooth and palate development. Dev Cell 15: 322-329.
44. Yew TL, Hung YT, Li HY, Chen HW, Chen LL, et al. (2011) Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Cell Transplant 20: 693-706.
45. Gallucci RM, Sloan DK, Heck JM, Murray AR, O'Dell SJ, (2004) Interleukin 6 indirectly induces keratinocyte migration. J Invest Dermatol 122: 764-772.
46. Sugawara T, Gallucci RM, Simeonova PP, Luster MI, (2001) Regulation and role of interleukin 6 in wounded human epithelial keratinocytes. Cytokine 15: 328-336.
47. Murphy KE, Hall CL, McCue SW, Sean McElwain DL, (2011) A two-compartment mechanochemical model of the roles of transforming growth factor beta and tissue tension in dermal wound healing. J Theor Biol 272: 145-159.
48. Zheng Z, Nguyen C, Zhang X, Khorasani H, Wang JZ, et al. (2011) Delayed wound closure in fibromodulin-deficient mice is associated with increased TGF-beta3 signaling. J Invest Dermatol 131: 769-778.
49. Amjad SB, Carachi R, Edward M, (2007) Keratinocyte regulation of TGF-beta and connective tissue growth factor expression: a role in suppression of scar tissue formation. Wound Repair Regen 15: 748-755.